Towards a safe and scalable cell therapy for type 1 diabetes by simplifying beta cell differentiation - Medical Xpress

Towards a safe and scalable cell therapy for type 1 diabetes by simplifying beta cell differentiation Medical Xpress More than 36 million people globally are affected by type 1 diabetes (T1D), a lifelong disorder where insulin producing cells are attacked and destroyed by the immune system resulting in deficient insulin production that requires daily blood glucose ... and more »

from diabetes - Google News